This story was originally published on Food Dive. To receive daily news and insights, subscribe to our free daily Food Dive newsletter. Dive Brief: Archer-Daniels-Midland Co. CEO Juan Luciano said its ingredients business is “"on the path to recovery,”" more than a year after the crop trader's nutrition unit was swept up in a broad accounting scandal. Luciano said in an earnings call that demand for flavors, particularly among the beverage industry, raised operating revenue at the nutrition segment by 13% in the first quarter compared to last year. The improved performance in nutrition was a small bright spot in an otherwise dour sales environment for ADM. Operating profits in the first quarter were down by 38% compared to the prior year, as the crop trader contends with trade uncertainty. Dive Insight: As the food and beverage industries face pressure from the Trump administration to phase out artificial dyes, ADM's ingredients unit is seeing more demand for natural colors, which Luciano hopes could drive future growth for the beleaguered nutrition business. ADM's nutrition unit, which includes its flavor and ingredients businesses, has struggled to regain its footing following a criminal probe into the segment's accounting practices. The investigation, which looked into whether ADM overstated profits in the segment, prompted the departure of the company’s CFO and a significant downsizing of the company’s nutrition offerings. The company has also seen delays in restarting operations at its specialty ingredient manufacturing facility in Decatur, Illinois, following a plant explosion in 2023. Luciano said the company made “important progress” in getting the facility back online, and that the plant is in the “final stages of recommissioning.” ADM has moved to cut costs as tariffs and uncertainty in biofuel regulations pressure overall earnings. The company announced a plan to eliminate up to 700 jobs and potentially sell assets to generate approximately $750 million in savings. It’s also focused on improving nutrition performance through a renewed focus on health and wellness. The company announced an agreement in February with Japan-based Asahi Group to distribute a postbiotic ingredient to improve sleep, stress and mood. Flavor demand boosted revenue at ADM’s Human Nutrition subsegment by 4%, according to the company’s Q1 earnings. “We continue to invest in R&D related to health and wellness solutions,” Luciano said on the call, adding that the company’s focus on nutrition is “beginning to show positive results.” Story Continues Recommended Reading ADM partners on postbiotics targeting sleep, stress View Comments
ADM ingredients business ‘on path to recovery’ after accounting scandal
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...